Endoscopic management of gastrointestinal motility disorders

Česká verze

Authors: J. Martínek ¹; K. Hugová ¹; D. Lovecká ²; R. Husťak ²
Authors place of work: Klinika hepatogastroenterologie, Institut klinické a experimentální medicíny, Praha ¹; Interná klinika, Fakultná nemocnica Trnava ²
Published in the journal: Rozhl. Chir., 2022, roč. 101, č. 1, s. 4-13.
Category: Souhrnné sdělení
doi: https://doi.org/10.33699/PIS.2022.101.1.4–13

Summary

Gastrointestinal motility disorders include several heterogeneous units affecting the esophagus, stomach, small or large intestine and the rectum. These are namely Zenker’s diverticulum, esophageal achalasia, gastroesophageal reflux disease, gastroparesis, constipation, Ogilvie’s syndrome and post-fundoplication dysphagia. Given the progressive development of endoscopic techniques, patients with most of the above mentioned diseases can be offered a solution consisting of a mini-invasive endoscopic procedure which has already become a first-choice treatment for some of the disorders. This article summarizes the current role of endoscopy in the treatment of the most important gastrointestinal motility disorders.

Keywords:

achalasia – Gastrointestinal motility disorders – endoscopic treatment – gastroparesis – Zenker´s diverticulum

Zdroje

1. Bizzotto A, Iacopini F, Landi R, et al. Zenker‘ s diverticulum: exploring treatment options. Acta Otorhinolaryngol Ital. 2013;33(4):219–29.

2. Weusten BLAM, Barret M, Bredenoord AJ, et al. Endoscopic management of gastrointestinal motility disorders – part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52(7):600−614. doi:10.1055/a-1171-3174.

3. Howell RJ, Giliberto JP, Harmon J, et al. Open versus endoscopic surgery of Zenker‘s diverticula: A systematic review and meta-analysis. Dysphagia 2019;34(6):930–938. doi:10.1007/s00455- 019-09994-9.

4. Ishaq S, Hassan C, Antonello A, et al. Flexible endoscopic treatment for Zenker’s diverticulum: A systematic review and meta-analysis. Gastrointest Endosc. 2016;83:1076–89.e5. doi:10.1016/j. gie.2016.01.039.

5. Martínek J, Siroký M, Plottová Z, et al. Treatment of patients with achalasia with botulinum toxin: a multicenter prospective cohort study. Dis Esophagus 2003;16(3):204–209. doi:10.1046/j.1442- 2050.2003.00329.x.

6. van Hoeij FB, Tack JF, Pandolfino JE, et al. Complications of botulinum toxin injections for treatment of esophageal motility disorders. Dis Esophagus 2017;30(3):1– 5. doi:10.1111/dote.12491.

7. Weusten BLAM, Barret M, Bredenoord AJ, et al. Endoscopic management of gastrointestinal motility disorders − part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020;52(6):498–515. doi:10.1055/a-1160-5549.

8. Ross SW, Oommen B, Wormer BA, et al. National outcomes of laparoscopic Heller myotomy: operative complications and risk factors for adverse events. Surg Endosc. 2015;29(11):3097–105. doi:10.1007/s00464-014-4054-0.

9. Nabi Z, Reddy DN, Ramchandani M. Adverse events during and after per-oral endoscopic myotomy: prevention, diagnosis, and management. Gastrointest Endosc. 2018;87(1):4–17. doi:10.1016/j. gie.2017.09.029.

10. Werner YB, Hakanson B, Martinek J, Repici A, et al. Endoscopic or surgical myotomy in patients with idiopathic achalasia. N Engl J Med. 2019;381(23):2219–2229. doi:10.1056/NEJMoa1905380.

11. Martinek J, Svecova H, Vackova Z, et al. Per-oral endoscopic myotomy (POEM): mid-term efficacy and safety. Surg Endosc. 2018;32(3):1293–302. doi:10.1007/ s00464-017-5807-3.

12. Yadlapati R, Hungness ES, Pandolfino JE. Complications of antireflux surgery. Am J Gastroenterol. 2018 Aug;113(8):1137– 1147. doi:10.1038/s41395-018-0115-7.

13. Richter JE, Kumar A, Lipka S, et al. Efficacy of laparoscopic Nissen fundoplication vs transoral incisionless fundoplication or proton pump inhibitors in patients with gastroesophageal reflux disease: A systematic review and network meta-analysis. Gastroenterology 2018;154(5):1298−1308.e7. doi:10.1053/j. gastro.2017.12.021.

14. Aziz AM, El-Khayat HR, Sadek A, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010;24(4):818–825. doi:10.1007/s00464- 009-0671-4.

15. Ye Y, Jiang B, Manne S, et al. Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut 2021;70(4):644– 653. doi:10.1136/gutjnl-2020-321277.

16. Friedenberg FK, Palit A, Parkman HP, et al. Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2008;103(2):416–423. doi:10.1111/j.1572-0241.2007.01676.x.

17. Arts J, Holvoet L, Caenepeel P, et al. Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007;26(9):1251–1258. doi:10.1111/j.1365-2036.2007.03467.x.

18. Erhartova D, Vackova Z, Hustak R, et al. Peroral endoscopic myotomy and peroral endoscopic pyloromyotomy as a single procedure for concomitant achalasia and gastroparesis. Endoscopy 2018;50(12):E336−E337. doi:10.1055/a-0658-5691.

19. Vosoughi K, Ichkhanian Y, Benias P, et al. Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial. Gut 2022 Jan;71(1):25–33. doi: 10.1136/gutjnl-2020-322756

20. Khashab MA, Stein E, Clarke JO, et al. Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc. 2013;78(5):764−768. doi: 10.1016/j.gie.2013.07.019.

21. Husťak R, Vacková Z, Krajciova J, et al. Peroral endoscopic pyloromyotomy (g-poem) for the treatment of gastroparesis − a pilot single-centre study with mid-term follow-up. Rozhl Chir. 2020;99(3):116–23. doi:10.33699/PIS.2020.99.3.116-123.

22. Tsirline VB, Zemlyak AY, Avery MJ, et al. Colonoscopy is superior to neostigmine in the treatment of Ogilvie‘s syndrome. Am J Surg. 2012;204(6):849–855; discussion 855. doi:10.1016/j.amjsurg. 2012.05.006.

23. Peker KD, Cikot M, Bozkurt MA, et al. Colonoscopic decompression should be used before neostigmine in the treatment of Ogilvie‘s syndrome. Eur J Trauma Emerg Surg. 2017;43(4):557−566. doi:10.1007/ s00068-016-0709-y.

24. Sgouros SN, Vlachogiannakos J, Vassiliadis K, et al. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial. Gut 2006;55(5):638−642. doi:10.1136/gut.2005.082099.

25. Hui J. Esophageal pneumatic dilation for postfundoplication dysphagia: safety, efficacy, and predictors of outcome. Am J Gastroenterol. 2002;97(12):2986–991. doi:10.1016/S0002-9270(02)05532-6.

26. Schuitenmaker JM, van Hoeij FB, Schijven MP, et al. Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial. Gut 2022 Jan;71(1):10−15. doi: 10.1136/ gutjnl-2020-322355.

27. Gonzalez JM, Monino L, Ah-Soune P, et al. Peroral endoscopic myotomy (POEM) for dysphagia and esophageal motor disorder after antireflux fundoplication. Endoscopy 2020;52(7):583–588. doi:10.1055/a-1147−1348.